Mohamed Teleb

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Oxide Nanoparticles

Immune Response

Angiotensin Converting Enzyme

Molecular Docking

Top Venues

Nanomedicine (London, England)

Future virology

Journal of enzyme inhibition and medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) 17 (22) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) 17 (22) (2023)
Assem Barakat, Saeed Alshahrani, Abdullah Mohammed Al-Majid, Abdullah Saleh Alamary, Matti Haukka, Marwa M Abu-Serie, Luis R Domingo, Sajda Ashraf, Zaheer Ul Haq, Mohamed S Nafie, Mohamed Teleb
New spiro-indeno[1,2- b ]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) 17 (22) (2023)
Amira R Khattab, Mohamed Teleb
In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery. Future virology (0) (2022)
Amira R Khattab, Mohamed Teleb, Mohamed S Kamel
In silico study of potential anti-SARS cell entry phytoligands from Phlomis aurea: a promising avenue for prophylaxis. Future virology (0) (2021)
Hosam H Khalil, Heba A Osman, Mohamed Teleb, A I Darwish, Marwa M Abu-Serie, Sherine N Khattab, Nesreen S Haiba
Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma. ChemMedChem (2021)